早發(fā)冠心病患者高密度脂蛋白抗炎作用的機(jī)制研究
發(fā)布時(shí)間：2018-10-25 10:59
【摘要】：目的:探討早發(fā)冠心病患者高密度脂蛋白(High Density Lipoprotein,HDL)與健康受試者HDL相比對(duì)氧化型低密度脂蛋白(Oxidized Low-Density Lipoprotein,ox-LDL)誘導(dǎo)的人臍靜脈內(nèi)皮細(xì)胞(Human Umbilical Vein Endothelial Cells,HUVECs)炎癥反應(yīng)影響的區(qū)別及可能的機(jī)制,進(jìn)一步明確早發(fā)冠心病的發(fā)病機(jī)制,為早發(fā)冠心病的臨床防治提供新思路。方法:1.選取符合實(shí)驗(yàn)條件的健康受試者(男性55歲,女性65歲)及相應(yīng)年齡的早發(fā)冠心病患者(男性55歲,女性65歲),采集血樣,密度梯度離心法分離HDL;2.ox-LDL處理HUVECs不同時(shí)間,通過Elisa法檢測(cè)細(xì)胞上清液中的炎癥因子如高遷移率族蛋白B1(High Mobility Group Protein Box 1,HMGB-1)、腫瘤壞死因子-α(Tumor Necrosis Factor-α,TNF-α)、細(xì)胞間黏附分子-1(Intercellular Cell Adhesion Molecule-1,ICAM-1)的表達(dá)情況,通過Western Blot檢測(cè)炎癥通路分子HMGB-1及晚期糖基化終末產(chǎn)物受體(Receptor for Advanced Glycation End Product,RAGE)的表達(dá)情況,明確炎癥反應(yīng)最顯著的時(shí)間點(diǎn);3.不同濃度的HDL孵育HUVECs相應(yīng)時(shí)間后,檢測(cè)上述炎癥分子及炎癥通路分子的表達(dá)情況,明確HDL抗炎作用最顯著的濃度;4.比較早發(fā)冠心病患者HDL和健康受試者HDL抗炎作用是否具有差異。結(jié)果:1.50mg/L ox-LDL可以誘導(dǎo)HUVECs產(chǎn)生炎癥反應(yīng),隨著時(shí)間的延長(zhǎng)細(xì)胞上清液中HMGB-1、TNF-α及ICAM-1的水平升高(P0.05),在48小時(shí)達(dá)到高峰;細(xì)胞HMGB-1、RAGE蛋白表達(dá)量升高,在24小時(shí)達(dá)到高峰,48小時(shí)表達(dá)量降低,但仍較正常細(xì)胞表達(dá)量高,RAGE表達(dá)量一直處于升高狀態(tài),在48小時(shí)達(dá)到高峰(P0.05)。2.HDL對(duì)ox-LDL誘導(dǎo)的HUVECs的炎癥反應(yīng)具有抑制作用,細(xì)胞上清液中HMGB-1、TNF-α、ICAM-1的水平及細(xì)胞HMGB-1、RAGE蛋白表達(dá)量隨著HDL濃度的增加而降低(P0.05),當(dāng)HDL濃度達(dá)到200mg/L時(shí)上述炎癥分子的表達(dá)量最低,說明此時(shí)HDL對(duì)炎癥反應(yīng)的抑制作用最顯著(P0.05)。3.早發(fā)冠心病患者HDL組與健康受試者HDL組相比,細(xì)胞上清液中HMGB-1、TNF-α、ICAM-1的水平及細(xì)胞HMGB-1、RAGE蛋白表達(dá)量較高,但與模擬組相比上述分子水平較低,與空白組相比上述分子水平較高(P0.05)。結(jié)論:1.HDL可以通過抑制人臍靜脈內(nèi)皮細(xì)胞HMGB-1/RAGE炎癥通路發(fā)揮抗炎作用。2.早發(fā)冠心病患者HDL與健康受試者HDL相比,其抗炎作用減弱,可能與其對(duì)HMGB-1/RAGE炎癥通路的抑制作用減弱有關(guān)。提示HMGB-1/RAGE炎癥通路可能作為早發(fā)冠心病防治的靶點(diǎn)。
[Abstract]:Objective: to investigate the effect of high density lipoprotein (High Density Lipoprotein,HDL) on oxidative low density lipoprotein (Oxidized Low-Density Lipoprotein,ox-LDL) -induced inflammation of human umbilical vein endothelial cells (Human Umbilical Vein Endothelial Cells,HUVECs) and its possible mechanism in patients with premature coronary heart disease (CHD) compared with healthy subjects (HDL). To further clarify the pathogenesis of early coronary heart disease and provide a new idea for clinical prevention and treatment of early onset coronary heart disease. Methods: 1. Blood samples were collected from healthy subjects (male 55 years old, female 65 years old) and premature coronary heart disease patients (55 years old for males and 65 years old for women). HDL;2.ox-LDL was separated by density gradient centrifugation to treat HUVECs for different time. The expression of inflammatory factors, such as high mobility group protein B1 (High Mobility Group Protein Box 1 (HMGB-1), tumor necrosis factor- 偽 (Tumor Necrosis Factor- 偽 (TNF- 偽) and intercellular adhesion molecule-1 (Intercellular Cell Adhesion Molecule-1,ICAM-1), was detected by Elisa assay. The expression of HMGB-1 and advanced glycosylation end product receptor (Receptor for Advanced Glycation End Product,RAGE) was detected by Western Blot to determine the most significant time point of inflammatory reaction. 3. After HUVECs was incubated with different concentrations of HDL, the expression of the above inflammatory molecules and inflammatory pathway molecules was detected, and the most significant anti-inflammatory effect of HDL was determined. 4. To compare the anti-inflammatory effects of HDL and HDL in patients with early coronary heart disease (CHD). Results: 1.50mg/L ox-LDL could induce the inflammatory reaction of HUVECs, and the levels of HMGB-1,TNF- 偽 and ICAM-1 in the supernatant of cells increased with time (P0.05) and reached the peak at 48 hours, the expression of HMGB-1,RAGE protein increased, reached the peak at 24 hours, and decreased at 48 hours. However, the expression of RAGE was still higher than that of normal cells, and the expression of RAGE reached its peak at 48 hours (P0.05). 2.HDL could inhibit the inflammatory response of HUVECs induced by ox-LDL. The levels of HMGB-1,TNF- 偽, ICAM-1 and the expression of HMGB-1,RAGE protein in the supernatant decreased with the increase of HDL concentration (P0.05). The lowest expression of the above inflammatory molecules was found when the HDL concentration reached 200mg/L, indicating that HDL had the most significant inhibitory effect on inflammatory response (P0.05). The levels of HMGB-1,TNF- 偽, ICAM-1 and the expression of HMGB-1,RAGE protein in the supernatant of the HDL group were higher than those in the control group, but lower than those in the simulated group and higher than those in the blank group (P0.05). Conclusion: 1.HDL can play an anti-inflammatory effect by inhibiting the HMGB-1/RAGE inflammatory pathway of human umbilical vein endothelial cells. 2. The anti-inflammatory effect of HDL in patients with premature coronary heart disease is weaker than that in healthy subjects compared with HDL, which may be related to the decrease of its inhibitory effect on the inflammatory pathway of HMGB-1/RAGE. The results suggest that the HMGB-1/RAGE inflammatory pathway may be a target for the prevention and treatment of early onset coronary heart disease.
【學(xué)位授予單位】：山西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R541.4
本文編號(hào)：2293513
[Abstract]:Objective: to investigate the effect of high density lipoprotein (High Density Lipoprotein,HDL) on oxidative low density lipoprotein (Oxidized Low-Density Lipoprotein,ox-LDL) -induced inflammation of human umbilical vein endothelial cells (Human Umbilical Vein Endothelial Cells,HUVECs) and its possible mechanism in patients with premature coronary heart disease (CHD) compared with healthy subjects (HDL). To further clarify the pathogenesis of early coronary heart disease and provide a new idea for clinical prevention and treatment of early onset coronary heart disease. Methods: 1. Blood samples were collected from healthy subjects (male 55 years old, female 65 years old) and premature coronary heart disease patients (55 years old for males and 65 years old for women). HDL;2.ox-LDL was separated by density gradient centrifugation to treat HUVECs for different time. The expression of inflammatory factors, such as high mobility group protein B1 (High Mobility Group Protein Box 1 (HMGB-1), tumor necrosis factor- 偽 (Tumor Necrosis Factor- 偽 (TNF- 偽) and intercellular adhesion molecule-1 (Intercellular Cell Adhesion Molecule-1,ICAM-1), was detected by Elisa assay. The expression of HMGB-1 and advanced glycosylation end product receptor (Receptor for Advanced Glycation End Product,RAGE) was detected by Western Blot to determine the most significant time point of inflammatory reaction. 3. After HUVECs was incubated with different concentrations of HDL, the expression of the above inflammatory molecules and inflammatory pathway molecules was detected, and the most significant anti-inflammatory effect of HDL was determined. 4. To compare the anti-inflammatory effects of HDL and HDL in patients with early coronary heart disease (CHD). Results: 1.50mg/L ox-LDL could induce the inflammatory reaction of HUVECs, and the levels of HMGB-1,TNF- 偽 and ICAM-1 in the supernatant of cells increased with time (P0.05) and reached the peak at 48 hours, the expression of HMGB-1,RAGE protein increased, reached the peak at 24 hours, and decreased at 48 hours. However, the expression of RAGE was still higher than that of normal cells, and the expression of RAGE reached its peak at 48 hours (P0.05). 2.HDL could inhibit the inflammatory response of HUVECs induced by ox-LDL. The levels of HMGB-1,TNF- 偽, ICAM-1 and the expression of HMGB-1,RAGE protein in the supernatant decreased with the increase of HDL concentration (P0.05). The lowest expression of the above inflammatory molecules was found when the HDL concentration reached 200mg/L, indicating that HDL had the most significant inhibitory effect on inflammatory response (P0.05). The levels of HMGB-1,TNF- 偽, ICAM-1 and the expression of HMGB-1,RAGE protein in the supernatant of the HDL group were higher than those in the control group, but lower than those in the simulated group and higher than those in the blank group (P0.05). Conclusion: 1.HDL can play an anti-inflammatory effect by inhibiting the HMGB-1/RAGE inflammatory pathway of human umbilical vein endothelial cells. 2. The anti-inflammatory effect of HDL in patients with premature coronary heart disease is weaker than that in healthy subjects compared with HDL, which may be related to the decrease of its inhibitory effect on the inflammatory pathway of HMGB-1/RAGE. The results suggest that the HMGB-1/RAGE inflammatory pathway may be a target for the prevention and treatment of early onset coronary heart disease.
【學(xué)位授予單位】：山西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R541.4
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李華明;歐志君;李艷;區(qū)景松;;高密度脂蛋白功能改變可能是動(dòng)脈粥樣硬化形成的危險(xiǎn)因素[J];中國(guó)動(dòng)脈硬化雜志;2015年12期
2 夏芳芳;欒天竹;梁兆光;姜超;楊建;;HMGB1與冠心病關(guān)系的研究進(jìn)展[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2015年29期
3 潘兵;孔金閣;趙明明;鄭樂民;;HDL通過ANXA1發(fā)揮對(duì)內(nèi)皮細(xì)胞保護(hù)功能[J];中國(guó)病理生理雜志;2015年10期
4 楊惠月;邊云飛;李小雷;尚冬升;;青年冠心病患者臨床危險(xiǎn)因素分析[J];山西醫(yī)科大學(xué)學(xué)報(bào);2015年05期
5 張舒媚;包金蘭;孫潤(rùn)陸;黃燦霞;陳清群;周淑嫻;張玉玲;;早發(fā)冠心病患者血清MCP-1與HDL2、HDL3水平及其相關(guān)性分析[J];中山大學(xué)學(xué)報(bào)(醫(yī)學(xué)科學(xué)版);2015年03期
6 趙莉;姚樹桐;王義圍;秦樹存;;高密度脂蛋白蛋白成分修飾對(duì)其抗動(dòng)脈粥樣硬化功能的影響[J];中國(guó)動(dòng)脈硬化雜志;2014年10期
7 翟振麗;馬維紅;李全忠;申煒;;高密度脂蛋白功能差異與動(dòng)脈粥樣硬化的研究進(jìn)展[J];實(shí)用醫(yī)學(xué)雜志;2013年21期
8 于鵬;姜紅;;高遷移率族蛋白1與心血管疾病關(guān)系概述[J];中國(guó)分子心臟病學(xué)雜志;2013年02期
9 韓菲菲;陳國(guó)千;;高遷移率族蛋白B1細(xì)胞外釋放及信號(hào)轉(zhuǎn)導(dǎo)機(jī)制[J];醫(yī)學(xué)研究生學(xué)報(bào);2013年03期
10 張婷;夏敏;;高遷移率族蛋白B1信號(hào)轉(zhuǎn)導(dǎo)通路的研究進(jìn)展[J];醫(yī)學(xué)綜述;2011年02期
相關(guān)博士學(xué)位論文 前1條
1 陳國(guó)良;早發(fā)冠心病患者高密度脂蛋白（HDL）蛋白質(zhì)組學(xué)研究[D];中國(guó)協(xié)和醫(yī)科大學(xué);2010年
，本文編號(hào)：2293513
本文鏈接：http://sikaile.net/yixuelunwen/xxg/2293513.html
最近更新
教材專著
